In this study, the use of systemically administered HE with high-dose BMP2 compared to rats not on HE and treated with the same dose of the growth factor, led to a substantial and significant decrease in osteopontin and smad4 expression, important in osteogenic signaling and mineralization. Here, BMP2 is linked to hereditary elliptocytosis.